"BladderBRIDGister": Translational Real-World-Registry with Clinical and Molecularpathological Data

"BladderBRIDGister": Translational Real-World-Registry with Clinical and Molecularpathological Data - BladderBRIDGister / URIMARK-plus / Uromonitor-Studie / Uromonitor-2-Studie

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027128

Enrollment

10000

Registered

2022-01-17

Start date

2018-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67.8

Interventions

Group 1: - Patient Age (in years) - Gender - ECOG preoperative - ECOG / WHO - smoking status - smoking in package years) - Body-Mass-Index (in kg/m2) - Profession - further diseases - drugs - pT-Stad

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with suspected bladder cancer Patients without evidence of urothelial carcinoma who undergo cystoscopy due to benign pathology (stone therapy, deobstructive therapy of BPS, etc.) and thus act as a healthy comparison group

Exclusion criteria

Exclusion criteria: pregnancy Lack of reconnaissance ability

Design outcomes

Primary

Measure	Time frame
progression free survival Sensitivity	—

Secondary

Measure	Time frame
RFS, DSS, QoL Specificity, PPV, NPV, accuracy, AUC of diagnostic performance	—

Countries

Germany

Contacts

Public ContactThorsten Ecke

Helios Klinikum Bad Saarow

thorsten.ecke@charite.de+493363172267

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026